Host biomarkers are associated with progression to dengue haemorrhagic fever: a nested case-control study
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
Authors: Conroy, Andrea L.; Gelvez, Margarita; Hawkes, Michael; Rajwans, Nimerta; Tran, Vanessa; Liles, W. Conrad; Angel Villar-Centeno, Luis; Kain, Kevin C.
Abstract
Objectives: Dengue represents the most important arboviral infection worldwide. Onset of circulatory collapse can be unpredictable. Biomarkers that can identify individuals at risk of plasma leakage may facilitate better triage and clinical management. Design: Using a nested case-control design, we randomly selected subjects from a prospective cohort study of dengue in Colombia (n = 1582). Using serum collected within 96 hours of fever onset, we tested 19 biomarkers by ELISA in cases (developed dengue hemorrhagic fever or dengue shock syndrome (DHF/DSS); n = 46), and controls (uncomplicated dengue fever (DF); n = 65) and healthy controls (HC); n = 15. Results: Ang-1 levels were lower and angptl3, sKDR, sEng, sICAM-1, CRP, CXCL10/IP-10, IL-18 binding protein, CHI3L1, C5a and Factor D levels were increased in dengue compared to HC. sICAM-1, sEng and CXCL10/IP-10 were further elevated in subjects who subsequently developed DHF/DSS (p = 0.008, p = 0.028 and p = 0.025, respectively). In a logistic regression model, age (odds ratio (OR) (95% CI): 0.95 (0.92-0.98), p = 0.001), hyperesthesia/hyperalgesia (OR; 3.8 (1.4-10.4), p = 0.008) and elevated sICAM-1 (>298ng/mL: OR; 6.3 (1.5-25.7), p = 0.011) at presentation were independently associated with progression to DHF/DSS. Conclusions: These results suggest that inflammation and endothelial activation are important pathways in the pathogenesis of dengue and sICAM-1 levels may identify individuals at risk of plasma leakage. (C) 2015 The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
Plasma YKL-40 in Inuit and Danes
ALCOHOL AND ALCOHOLISM
Authors: Nojgaard, Camilla; Johansen, Julia S.; Bjerregaard, Peter; Bojesen, Stig E.; Becker, Ulrik
Abstract
Aims: The aim of the present study was to investigate whether there are differences in plasma levels of YKL-40 between Inuit in Greenland and in Denmark and in Danes, as well as to study the relationship between alcohol intake, plasma YKL-40 and other factors in Inuit. Methods: Plasma YKL-40 levels were measured on 1645 people from The Greenland Population Study (a cross-sectional population study of Inuit from Denmark and West Greenland) and were compared with the plasma YKL-40 levels of 8899 people from The Copenhagen City Heart Study (a population-based, prospective study of the Danish general population). Results: The plasma concentrations of YKL-40 were significantly (P = 0.001) lower in Inuit living in Greenland (median 46 A mu g/l, range 10-2164, n = 1164) compared with the plasma YKL-40 levels of Inuit living in Denmark (median 63 A mu g/l, range 20-2827, n = 481) and of Danes living in Denmark (median 55 A mu g/l, range 10-2909, n = 8899). In Inuit, increased alcohol intake was significantly associated with increased plasma YKL-40 levels (P < 0.001), and high plasma YKL-40 levels were associated with high values of alkaline phosphatase and low values of albumin. Smoking, gender and bilirubin were not associated with the plasma YKL-40 level. High levels of YKL-40 and alcohol were associated with where people lived. Conclusion: The plasma concentrations of YKL-40 are significantly lower in Inuit living in Greenland than Inuit and Danes living in Denmark. A number of factors, including different alcohol intake patterns, nutrition and genes may play a role in these findings.